Results 21 to 30 of about 1,013,993 (235)
Background Patients with severe acute respiratory syndrome coronavirus 2 infection show various clinical manifestations, including neurological .
Triana Ayuningtyas+4 more
doaj +1 more source
A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus strain that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. It spread to several countries across continents and infected more than one million people within three months. While there is no consensus on the treatment of the disease
Robert Hage+3 more
openaire +3 more sources
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame [PDF]
Lay Summary This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares.
and IG-IBD COVID-19 Study Group+6 more
core +1 more source
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre+6 more
doaj +1 more source
Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has infected millions of people. The conjunctival epithelium is easily exposed to infectious droplets and body fluids making eyes a potential route and reservoir of the infection.
Bibechan Thapa
doaj +1 more source
Secretion of severe acute respiratory syndrome coronavirus 2 in urine [PDF]
Purpose of review Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. Recent findings We could identify 34 publications including a total of 2172 patients.
Ursula Lemberger+6 more
openaire +3 more sources
Current Landscape of Mesenchymal Stem Cell Therapy in COVID Induced Acute Respiratory Distress Syndrome [PDF]
The severe acute respiratory syndrome coronavirus 2 outbreak in Chinas Hubei area in late 2019 has now created a global pandemic that has spread to over 150 countries. In most people, COVID 19 is a respiratory infection that produces fever, cough, and shortness of breath. Patients with severe COVID 19 may develop ARDS.
arxiv +1 more source
Clotting disorder in severe acute respiratory syndrome coronavirus 2 [PDF]
SummaryThe severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel human respiratory viral infection that has rapidly progressed into a pandemic, causing significant morbidity and mortality. Blood clotting disorders and acute respiratory failure have surfaced as the major complications among the severe cases of coronavirus disease 2019 (
Pujhari, Sujit+3 more
openaire +3 more sources
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2 [PDF]
In view of devastating effects of COVID-19 on human life, there is an urgent need for the licened vaccines or therapeutics for the SARS-CoV-2 infection. Age-old passive immunization with protective antibodies to neutralize the virus is one of the strategies for emergency prophylaxis and therapy for coronavirus disease 2019 (COVID-19).
Sajna, Kuttuvan Valappil, Kamat, Siya
openaire +2 more sources
Background: Despite investigating coronavirus among respiratory tract infected cases is a top priority to prevent further transmission, severe acute respiratory syndrome coronavirus 2 positivity among this group of patients remains unexplored in resource-
Abdi Birhanu+4 more
doaj +1 more source